RIL
CRDF icon

Rothschild Investment LLC’s Cardiff Oncology CRDF Stock Holding History

Rothschild Investment LLC’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117 Buy
90
+79
+718% +$125 ﹤0.01% 3503
2026
Q1 		$18 Buy
+11
New +$23 ﹤0.01% 3545

Other funds holding CRDF

LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Rothschild Investment LLC's CRDF Position: Q2 2026 in Review

Rothschild Investment LLC increased its Cardiff Oncology (CRDF) stake by 718% in Q2 2026, buying an estimated $125 and bringing the position to 90 shares worth $117. The position accounts for ﹤0.01% of the portfolio, ranked #3503.

Rothschild Investment LLC first reported a position in CRDF in Q1 2026 and has held it in 2 quarters since. 105 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Rothschild Investment LLC held 90 shares of Cardiff Oncology worth $117 as of Q2 2026.
  • Rothschild Investment LLC bought 79 Cardiff Oncology shares in Q2 2026, an estimated $125.
  • Cardiff Oncology made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3503 holding.
  • Rothschild Investment LLC first reported a position in Cardiff Oncology in Q1 2026 and has held it in 2 quarters since.
  • 105 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.